Recent Advances in the Treatment of ST-Segment Elevation Myocardial Infarction

Dear Colleagues,

The incidence of ST-elevation myocardial infarction (STEMI) in European countries ranges between 40 and 140/100 000/year, which equates to over 500,000 patients with STEMI being admitted to hospital each year. Despite improvements in management, STEMI remains one of the leading causes of death in Europe, as well as globally. The gold standard of treatment of STEMI is acute reperfusion therapy, preferably with primary percutaneous coronary intervention (PCI). Further efforts should made to improve the quality of care for STEMI patients. Continuous public awareness campaigns should be performed to develop understanding of the condition and reduce the interval between the onset of symptoms and first medical contact; improvements of logistics should be implemented to minimize delays so as to increase the number of patients treated with primary PCI within 120 min, or preferably, 60 min after first medical contact. Future research is needed to reduce mortality in patients with cardiogenic shock or in patients presenting with STEMI and following events of out-of-hospital cardiac arrest.

The present Special Issue aims to overview the current knowledge, latest evidence, and unresolved issues regarding the treatment of STEMI. Therefore, I welcome the submission of innovative, original research papers and in-depth review articles dealing with pioneering management and/or treatment techniques of STEMI.

Dr. Édouard Gerbaud
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.